Literature DB >> 3871155

Computed tomography of osteosarcoma after intraarterial chemotherapy.

A Shirkhoda, N Jaffe, S Wallace, A Ayala, M M Lindell, J Zornoza.   

Abstract

The response to intraarterial cis-diamminedichloroplatinum II (CDP) chemotherapy was evaluated by computed tomography (CT) in 33 patients with pathologically proved osteosarcoma of the long or flat bones. Twenty-one of the 33 patients had a CT scan before chemotherapy was started. In the other 12 patients, a CT scan was obtained after at least two courses of treatment, and additional studies were performed during the course of therapy. In those patients responding to treatment, the posttherapy scan revealed a remarkable decrease or complete disappearance of the associated soft-tissue mass and clear reestablishment of the fat planes between the muscle bundles that had been obscured. There was sharp definition of the peripheral margins of the calcified healing neoplasm, and the calcification in the healing tumor could be differentiated easily from that of the original bone neoplasm. The findings of CT were compared with those of conventional studies and pathologic results. CT was more accurate than conventional studies in detecting healing process and diagnosis of remission.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871155     DOI: 10.2214/ajr.144.1.95

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  4 in total

1.  The angiographic response of osteosarcoma following pre-operative chemotherapy.

Authors:  W Kumpan; G Lechner; G R Wittich; M Salzer-Kuntschik; G Delling; R Kotz; P Hajek; J Sekera
Journal:  Skeletal Radiol       Date:  1986       Impact factor: 2.199

2.  Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology.

Authors:  J Knop; G Delling; U Heise; K Winkler
Journal:  Skeletal Radiol       Date:  1990       Impact factor: 2.199

3.  The Current and Future Therapies for Human Osteosarcoma.

Authors:  Joseph D Lamplot; Sahitya Denduluri; Jiaqiang Qin; Ruidong Li; Xing Liu; Hongyu Zhang; Xiang Chen; Ning Wang; Abdullah Pratt; Wei Shui; Xiaoji Luo; Guoxin Nan; Zhong-Liang Deng; Jinyong Luo; Rex C Haydon; Tong-Chuan He; Hue H Luu
Journal:  Curr Cancer Ther Rev       Date:  2013-02

4.  A Scoring System for Predicting Neoadjuvant Chemotherapy Response in Primary High-Grade Bone Sarcomas: A Multicenter Study.

Authors:  Fangzhou He; Lu Xie; Xin Sun; Jie Xu; Yuan Li; Rong Liu; Kunkun Sun; Danhua Shen; Jin Gu; Tao Ji; Wei Guo
Journal:  Orthop Surg       Date:  2022-08-26       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.